Krystal Biotech stockholders elect directors, ratify auditor, approve say-on-pay at 2024 annual meeting

Krystal Biotech, Inc.

Class I directors Suma M. Krishnan, Julian S. Gangolli, and Catherine Mazzacco elected with 21.1M, 17.2M, and 20.4M votes for, respectively.
Ratification of KPMG as independent auditor for FY2024: 24.8M for, 7.4K against, 22.8K abstentions.
Advisory approval of named executive officer compensation for FY2023: 21.7M for, 851.7K against, 7.0K abstentions.
Broker non-votes of 2.2M for director election and say-on-pay; no broker non-votes on auditor ratification.
All proposals passed with strong majority support; no material changes to board or governance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.